{"entity":{"type":"insider","cik":"0001376355","url":"/insider/0001376355","json_url":"/insider/0001376355.json","name":"Lichter Jay","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":69,"n_filings":15,"first":"2014-02-04","last":"2024-10-24","span_basis":"filed_date"},"name_variants":[{"name":"Lichter Jay","source":"filing","n_filings":15,"first_seen":"2014-02-04","last_seen":"2024-10-24"}],"transactions":[{"id":2070759,"accession":"0001415889-24-025436","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_display_name":"Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1461769.0,"shares_display":"1,461,769","price_per_share":45.76449240611889,"price_display":"45.76","price_state":"stated","total_value":66897116.3,"total_display":"66,897,116.30","total_whole":"66,897,116","shares_owned_after":2115373.0,"shares_owned_after_display":"2,115,373","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-18","scope":"insider","n_lines":9},{"id":2070741,"accession":"0001415889-24-025436","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436#line-16","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_display_name":"Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1843.0,"shares_display":"1,843","price_per_share":50.02,"price_display":"50.02","price_state":"stated","total_value":92186.86,"total_display":"92,186.86","total_whole":"92,187","shares_owned_after":6371.0,"shares_owned_after_display":"6,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-17","filed_date":"2024-10-18","scope":"insider"},{"id":2070729,"accession":"0001415889-24-025436","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001415889-24-025436","line_url":"/filing/0001415889-24-025436","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP; Lichter Jay","owner_display_name":"Avalon BioVentures SPV I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":209516.0,"shares_display":"209,516","price_per_share":50.03468980889288,"price_display":"50.03","price_state":"stated","total_value":10483068.07,"total_display":"10,483,068.07","total_whole":"10,483,068","shares_owned_after":2819366.0,"shares_owned_after_display":"2,819,366","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-18","scope":"insider","n_lines":7},{"id":3178471,"accession":"0001415889-24-024119","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119#line-22","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_display_name":"Lichter Jay","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":958.0,"shares_display":"958","price_per_share":46.24,"price_display":"46.24","price_state":"stated","total_value":44297.92,"total_display":"44,297.92","total_whole":"44,298","shares_owned_after":6887.0,"shares_owned_after_display":"6,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-30","filed_date":"2024-09-30","scope":"insider"},{"id":3178424,"accession":"0001415889-24-024119","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_display_name":"Lichter Jay","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106821.0,"shares_display":"106,821","price_per_share":46.45741530223458,"price_display":"46.46","price_state":"stated","total_value":4962627.56,"total_display":"4,962,627.56","total_whole":"4,962,628","shares_owned_after":2882353.0,"shares_owned_after_display":"2,882,353","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-09-30","scope":"insider","n_lines":7},{"id":3178362,"accession":"0001415889-24-024119","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-24-024119","line_url":"/filing/0001415889-24-024119","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures I, LP; Avalon BioVentures SPV I, L.P.","owner_display_name":"Lichter Jay","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":47.2273414,"price_display":"47.23","price_state":"stated","total_value":9445468.28,"total_display":"9,445,468.28","total_whole":"9,445,468","shares_owned_after":2970875.0,"shares_owned_after_display":"2,970,875","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-26","filed_date":"2024-09-30","scope":"insider","n_lines":6},{"id":3178781,"accession":"0001415889-24-025601","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-025601","line_url":"/filing/0001415889-24-025601#line-5","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":"0001376355","owner_name":"Lichter Jay","owner_display_name":"Lichter Jay","owner_url":"/insider/0001376355","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3815.0,"shares_display":"3,815","price_per_share":46.68,"price_display":"46.68","price_state":"stated","total_value":178084.2,"total_display":"178,084.20","total_whole":"178,084","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-10-24","scope":"insider"},{"id":2756550,"accession":"0001415889-24-023337","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001415889-24-023337","line_url":"/filing/0001415889-24-023337","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_display_name":"Lichter Jay","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350000.0,"shares_display":"350,000","price_per_share":47.0,"price_display":"47.00","price_state":"stated","total_value":16450000.0,"total_display":"16,450,000.00","total_whole":"16,450,000","shares_owned_after":3021414.0,"shares_owned_after_display":"3,021,414","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-12","scope":"insider","n_lines":3},{"id":2756535,"accession":"0001415889-24-023337","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-24-023337","line_url":"/filing/0001415889-24-023337","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_display_name":"Lichter Jay","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101091.0,"shares_display":"101,091","price_per_share":46.52856822071203,"price_display":"46.53","price_state":"stated","total_value":4703619.49,"total_display":"4,703,619.49","total_whole":"4,703,619","shares_owned_after":3182770.0,"shares_owned_after_display":"3,182,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider","n_lines":6},{"id":2900574,"accession":"0001415889-24-023153","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-24-023153","line_url":"/filing/0001415889-24-023153#line-8","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_display_name":"Lichter Jay","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2182.0,"shares_display":"2,182","price_per_share":42.33,"price_display":"42.33","price_state":"stated","total_value":92364.06,"total_display":"92,364.06","total_whole":"92,364","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-10","scope":"insider"},{"id":2900559,"accession":"0001415889-24-023153","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-023153","line_url":"/filing/0001415889-24-023153","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":null,"owner_name":"Lichter Jay; Avalon BioVentures SPV I, L.P.; Avalon BioVentures I, LP","owner_display_name":"Lichter Jay","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":240000.0,"shares_display":"240,000","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":10080000.0,"total_display":"10,080,000.00","total_whole":"10,080,000","shares_owned_after":3229374.0,"shares_owned_after_display":"3,229,374","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-06","filed_date":"2024-09-10","scope":"insider","n_lines":3},{"id":2131667,"accession":"0001415889-24-015678","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-015678","line_url":"/filing/0001415889-24-015678","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":"0001376355","owner_name":"Lichter Jay","owner_display_name":"Lichter Jay","owner_url":"/insider/0001376355","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500000.0,"shares_display":"1,500,000","price_per_share":54.75,"price_display":"54.75","price_state":"stated","total_value":82125000.0,"total_display":"82,125,000.00","total_whole":"82,125,000","shares_owned_after":3340018.0,"shares_owned_after_display":"3,340,018","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider","n_lines":3},{"id":8630928,"accession":"0001209191-23-055349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-055349","line_url":"/filing/0001209191-23-055349#line-1","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":"0001376355","owner_name":"Lichter Jay","owner_display_name":"Lichter Jay","owner_url":"/insider/0001376355","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":849854.0,"shares_display":"849,854","price_per_share":5.87,"price_display":"5.87","price_state":"stated","total_value":4988642.98,"total_display":"4,988,642.98","total_whole":"4,988,643","shares_owned_after":849854.0,"shares_owned_after_display":"849,854","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-13","filed_date":"2023-11-15","scope":"insider"},{"id":4140462,"accession":"0001209191-21-041038","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-041038","line_url":"/filing/0001209191-21-041038#line-6","is_derivative":false,"issuer_cik":"0001376355","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001376355","owner_cik":"0001376355","owner_name":"Lichter Jay","owner_display_name":"Lichter Jay","owner_url":"/insider/0001376355","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":629411.0,"shares_display":"629,411","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":10699987.0,"total_display":"10,699,987.00","total_whole":"10,699,987","shares_owned_after":4479492.0,"shares_owned_after_display":"4,479,492","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-16","scope":"insider"}],"collapsed":true,"next_cursor":"2021-06-15|4140462","ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001817713","name":"Janux Therapeutics, Inc.","url":"/issuer/0001817713","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2021-06-16","last_seen":"2024-10-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001493566","name":"OTONOMY, INC.","url":"/issuer/0001493566","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2014-08-19","last_seen":"2021-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001609727","name":"Synthorx, Inc.","url":"/issuer/0001609727","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2018-12-13","last_seen":"2018-12-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001509190","name":"ARATANA THERAPEUTICS, INC.","url":"/issuer/0001509190","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2014-02-04","last_seen":"2014-02-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001376355","retrieved_at":"2026-08-22T22:52:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}